News > Mumbai: Haffkine, Bharat Biotech to set up COVID vax production plant in Mumbai

Mumbai: Haffkine, Bharat Biotech to set up COVID vax production plant in Mumbai

In a major development, Haffkine Pharmaceuticals Corporation and Hyderabad-based Bharat Biotech will jointly produce COVID-19 drug COVAXIN with the establishment of a new plant on the Parel premises in south-central Mumbai at a cost of Rs 154 crore.

Chief Minister Uddhav Thackeray, who on Saturday visited the Haffkine, said it can commence the vaccine production after technology transfer under the guidance of the ICMR from Parel and Pimpri facilities or it can work on a fill and finish basis.